Faricimab-Associated Intraocular Inflammation With Features of Herpes Simplex Virus
- 25 February 2025
- journal article
- case report
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 273, 212-220
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Sterile Intraocular Inflammation Associated With FaricimabJAMA Ophthalmology, 2024
- Severe Intraocular Inflammation After Intravitreal Injection of Faricimab: A Single-Site Case Series of Six PatientsAmerican Journal of Ophthalmology, 2024
- Association of Occlusive Retinal Vasculitis With Intravitreal FaricimabJAMA Ophthalmology, 2024
- Severe Intraocular Inflammation Following Intravitreal FaricimabJAMA Ophthalmology, 2024
- Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective studyGraefe's Archive for Clinical and Experimental Ophthalmology, 2023
- Development of Classification Criteria for the UveitidesAmerican Journal of Ophthalmology, 2021
- HAWK and HARRIEROphthalmology, 2021
- Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of BrolucizumabOphthalmology, 2020
- Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJAMA Ophthalmology, 2020
- Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitisEuropean Journal of Cancer, 2017